Why is it never mentioned that maybe we are looking at two different groups of patients?
Oxford applies to 1-2% of the population, while CCC applies to 0.1-0.2%. Even if we consider clueless physicians who don’t use the criteria correctly, and even if these criteria are not perfect, it should be obvious that data from the 10% ME/CFS-sufferers would get lost when studied together with the 90% CF-patients. It sucks for the people who are struggling with CF too that there’s so much fighting, they could probably do with better targeted research too. That divorce is long overdue.